ChemDiv built an impressive track record over the past fifteen years and is proud to have worked with over eight hundred pharmaceutical, biotech and academic partners on a range of drug discovery research projects with varying models of financial and scientific collaboration.
These projects included: discovery and optimization of small molecules for a range of therapeutic targets and pathways in oncology, inflammation and CNS; the VIP discovery chemistry technology access program; the development of Focused Diversity™ chemical libraries for biological screening, and screening collaborations.
A few ChemDiv partner companies:
What partner companies say about ChemDiv
| 
